INS and fatty liver disease: Co-administration improved parameters such as body weight, adipocyte hypertrophy, insulin sensitivity, lipid profiles, hepatic steatosis, vascular function, and the expression of inflammation and oxidative stress, achieving effects not observed with each supplement alone.